Form 8-K - Current report:
SEC Accession No. 0001564590-20-052983
Filing Date
2020-11-10
Accepted
2020-11-10 16:18:14
Documents
3
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plrx-8k_20201110.htm 8-K 32704
2 EX-99.1 plrx-ex991_6.htm EX-99.1 314515
3 GRAPHIC ghc301lx1nuq000001.jpg GRAPHIC 2860
  Complete submission text file 0001564590-20-052983.txt   352435
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 201301351
SIC: 2834 Pharmaceutical Preparations